Cardiff Lexington (CDIX) Registration filing summary
Event summary combining transcript, slides, and related documents.
Registration filing summary
30 Jun, 2026Company overview and business model
Formed as a Cayman Islands exempted blank check company to effect a merger, share exchange, asset acquisition, or similar business combination with one or more businesses; no target selected or discussions initiated as of the IPO filing date.
May pursue a business combination in any industry, with a preference for sectors where the management team’s expertise provides a competitive advantage.
Management and sponsor are affiliated with KingsRock Advisors, a global financial advisory firm with a broad network and deep transaction experience.
The company leverages proprietary sourcing channels, a network of over 70 core team members and 125+ senior advisors, and strategic partners for deal origination and execution.
Investment criteria focus on businesses with strong management, proprietary sourcing, ability to leverage the SPAC network, attractive returns, and robust financials.
Financial performance and metrics
As of May 29, 2026, the company had no cash, a working capital deficit of $47,341, and had incurred $17,587 in general and administrative costs since inception.
No revenues generated to date; all activity relates to formation and IPO preparation.
The company’s ability to continue as a going concern is contingent on successful completion of the IPO.
Use of proceeds and capital allocation
$200 million (or $230 million if the over-allotment is exercised) from the IPO and private placement will be placed in a U.S.-based trust account, invested in U.S. government securities or money market funds.
Approximately $800,000 will be available outside the trust account for working capital, due diligence, legal, accounting, and administrative expenses.
Proceeds in the trust account will only be released upon completion of a business combination, redemption of shares, or liquidation.
Latest events from Cardiff Lexington
- SPAC raising $200M to acquire a target in 24 months, with strong sponsor ties and notable dilution risk.CDIX
Registration filing24 Jun 2026 - Q2 2025 revenue rose 90% with strong margins and positive adjusted EBITDA, despite higher interest expense.CDIX
Q2 202515 Jun 2026 - Revenue and profitability declined, but expansion and OTCQX uplisting support future growth.CDIX
Q1 202612 Jun 2026 - Q3 2025 revenue jumped 125.6% to $3.1M, with gross margin soaring to 62.4% and strong M&A-driven growth.CDIX
Q3 202512 Jun 2026 - Revenue up 40% to $11.5M, but net loss widened to $5.5M on higher interest expense.CDIX
Q4 202512 Jun 2026 - SPAC aims to raise $200M for a business combination, with high dilution and sponsor-favored terms.CDIX
Registration filing11 Jun 2026